Channel Medsystems' mission is to bring innovation to women's healthcare for the benefit of women, physicians, and the healthcare system. Our initial product offering, Cerene®, was developed to allow physicians to safely and effectively treat women with Heavy Menstrual Bleeding in the physician’s office. The novel cryo-based device was originally approved by the FDA supported by the largest Premarket Approval (PMA) pivotal study of its kind, and clearly established the benefits of the 2.5-minute treatment. The procedure was well-tolerated with minimal anesthesia resulting in a significant reduction in bleeding severity and dysmenorrhea and demonstrated the ability to access and systematically assess the uterine cavity 12 months post-procedure. The current generation Cerene device was approved by the FDA in 2020 and is now available for commercial use.
Call 510-338-9301 or email info@channelmedsystems.com for an in-office demonstration